Table 5.
Antiviral activity (EC50), toxicity (TC50), and selectivity index (SI; TC50/EC50) data for terminus-modified mercaptobenzamide prodrugs.
![]() | ||||
---|---|---|---|---|
Compound | R | EC50 [μM] | TC50 [μM] | SI |
56 | ![]() |
5.0 ± 3.1 | 92.0 ± 11.4 | 18.4 |
57 | ![]() |
4.7 ± 0.2 | 95.4 ± 6.6 | 20.3 |
58 | ![]() |
4.8 ± 0.8 | 29.3 ± 10.4 | 6.10 |
59 | ![]() |
10.3 ± 7.0 | 24.8 ± 19.5 | 2.41 |
60 | ![]() |
9.1 ± 6.7 | 46.8 ± 11.2 | 5.14 |
61 | ![]() |
6.6 ± 3.4 | 76.9 ± 10.8 | 11.6 |
62 | ![]() |
4.9 ± 1.1 | >100 | 20.4 |
63 | ![]() |
27.5 ± 25.7 | >100 | 3.64 |